The weekly litigation news digest is live. Subscribe now

IP Verse

Troponin As Marker For Intermittent Atrial Fibrillation - EP3088900

The patent EP3088900 was granted to F Hoffmann LA Roche on Aug 12, 2020. The application was filed on Oct 17, 2012 under application number EP16175468A. The patent is currently recorded with a legal status of "Revoked".

EP3088900

F HOFFMANN LA ROCHE
Application Number
EP16175468A
Filing Date
Oct 17, 2012
Status
Revoked
Feb 23, 2024
Publication Date
Aug 12, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
MATHYS & SQUIREMay 12, 2021GRIFFIN -

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0648228
DESCRIPTIONUS5744305
DESCRIPTIONWO02083913
DESCRIPTIONWO02089657
OPPOSITIONWO2010007041
OPPOSITIONWO2012025355

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents